Business
Author
Keith Howard
More from Keith Howard
Business
Business FDA clears Zoetis screwworm treatment for dogs and puppies
The FDA has authorised a New World Screwworm treatment for dogs from Zoetis, the fifth such emergency nod since the outbreak began.
Business Silver Lake Workday deal talk lifts shares sharply
Reuters says Silver Lake is in talks over a Workday deal that could value the software firm near $43bn. Here's what's confirmed - and what isn't.
Business Sandisk Investor Day Sparks Sharpest Rally in Months
Sandisk's investor day triggered a 15%+ share surge and lifted memory peers, reversing a 30% drawdown built on rising short bets.
Business Raspberry Pi and Filtronic shares: two FTSE growth stories worth watching now
Raspberry Pi and Filtronic shares are drawing fresh attention from investors who watched Rolls-Royce deliver a 1,338% return since mid-2021 and are now scanning the market for the next multi-year…
Business IREN Microsoft AI deal clears first hurdle, shares jump 10%
The IREN Microsoft AI deal moved from contract to concrete on 13 August, as Microsoft accepted the first of four data centres and shares jumped 10%.
Business S&P 500 Year-End Forecast Points to a 6% Gain — But Selective Bets May Do Better
The S&P 500 year-end forecast from Wall Street's major banks currently implies a return of just under 6% from current levels, based on a mean target of 7,857 points against…
Business SpaceX Stock Recovery Faces a Long Road After Its Historic IPO Frenzy
The case for a SpaceX stock recovery starts with understanding just how violent the opening act has been. Space Exploration Technologies (SPCX) priced its shares at $135 on 12 June…
Business Cisco Earnings After Hours: Why the Reports Disagree
Cisco earnings after hours produced two contradictory stock stories on Wednesday. Cerebras, Coherent and Infleqtion also drew attention - here's what checks out.
Business CoreWeave stock surge follows blowout AI earnings beat
The CoreWeave stock surge extended into a second day after Q2 revenue jumped 112% and guidance rose, though GAAP losses persist.
Business BT Share Price Outlook Dims as Government Blocks Bharti Stake Increase
The BT share price outlook has darkened over the past fortnight, with BT Group (LSE: BT.A) sliding around 15% from a peak of 240p on 11 May to 203p, as…
Business Raspberry Pi Share Price Faces 1,085p Target: Bull Case, Bear Case and Insider Activity
At 661p, the Raspberry Pi share price sits roughly 64% below the 1,085p target that Peel Hunt analysts placed on the FTSE 250 technology stock earlier this month, a gap…
Business How Axon Enterprise’s Q2 Results Shape Up an ISA Strategy
An Axon Enterprise ISA strategy looks somewhat different today than it did a fortnight ago: the Q2 2026 results that the snippet flagged as pending have now been reported, and…
Business Greggs Share Price Outlook Cools After 50% Fall From Peak
The Greggs share price outlook has shifted from cult growth story to cautious recovery case, with GRG trading at 1,620p after losing half its value from an August 2024 peak…
Business Rolls-Royce Share Price Forecast Points to Modest Gains as SMR Pipeline Builds
The Rolls-Royce share price forecast from City analysts points to a consensus target of 1,526p, roughly 6% above the current 1,446p, a number that feels almost anticlimactic for a stock…
Business BP Share Price Outlook Clouded by Rising Debt and Oil-Price Swings
The BP share price outlook remains hostage to a familiar pair of forces: the trajectory of crude oil and a balance sheet that keeps moving in the wrong direction. Net…
Business SpaceX Share Price 2026: Why the $135 IPO Level Remains the Key Test
The SpaceX share price in 2026 has traced a familiar post-IPO arc: a burst of enthusiasm, then gravity. SPCX, which priced its initial public offering at $135.00 per share on…
Business Rolls-Royce vs SpaceX Stock Comparison: Which Aerospace Play Fits a Long Portfolio?
The Rolls-Royce vs SpaceX stock comparison has sharpened considerably since SpaceX (SPCX) completed the largest IPO in history in June 2026, raising $75bn and eclipsing the $35.4bn record Saudi Aramco…
Business Faron Pharmaceuticals share price targets 762% on bexmarilimab trial momentum
Faron Pharmaceuticals share price is trading at 39.5p, yet analysts have set an average 12-month price target of 340p, implying a gain of 762% if the consensus proves correct. One…
Business Investec INVP dividend stock: 6% yield, 147% return and a P/E below 8
Investec (INVP) joined the FTSE 100 on 22 June, and the Investec INVP dividend stock arrived with credentials that most index newcomers cannot match: a trailing yield of 6.07%, a…
Business Lloyds Shares Forecast for 2027 Points to Further Gains
The Lloyds shares forecast for 2027 sits at an average analyst price target of 122p, roughly 9% above the current price of 112p, but more recent upgrades from Morgan Stanley,…
Business HSBC ISA Passive Income: Targeting £20,153 a Year to Top Up Your State Pension
Building a credible HSBC ISA passive income strategy is one of the more practical routes for UK investors trying to bridge the gap between the State Pension and what it…
Business Greggs Shares Broker Outlook Splits as H1 Profits Rebound 19.7%
The Greggs shares broker outlook has rarely been more divided: fifteen analysts, a neutral consensus, and a share price sitting near 1,600p after sliding from around 2,800p since 2025. What…
Business